Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia.
- Authors
- Rose, Emma Jane; Donohoe, Gary
- Year
- 2013
- Journal
- Schizophrenia bulletin
- PMID
- 22499782
- DOI
- 10.1093/schbul/sbs056
- PMCID
- PMC3627766
Genetic variants associated with increased risk for schizophrenia (SZ) are hypothesized to be more penetrant at the level of brain structure and function than at the level of behavior. However, to date the relative sensitivity of imaging vs cognitive measures of these variants has not been quantified. We considered effect sizes associated with cognitive and imaging studies of 9 robust SZ risk genes (DAOA, DISC1, DTNBP1, NRG1, RGS4, NRGN, CACNA1C, TCF4, and ZNF804A) published between January 2005-November 2011. Summary data was used to calculate estimates of effect size for each significant finding. The mean effect size for each study was categorized as small, medium, or large and the relative frequency of each category was compared between modalities and across genes. Random effects meta-analysis was used to consider the impact of experimental methodology on effect size. Imaging studies reported mostly medium or large effects, whereas cognitive investigations commonly reported small effects. Meta-analysis confirmed that imaging studies were associated with larger effects. Effect size estimates were negatively correlated with sample size but did not differ as a function of gene nor imaging modality. These observations support the notion that SZ risk variants show larger effects, and hence greater penetrance, when characterized using indices of brain structure and function than when indexed by cognitive measures. However, it remains to be established whether this holds true for individual risk variants, imaging modalities, or cognitive functions, and how such effects may be mediated by a relationship with sample size and other aspects of experimental variability.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Lorcaserin modulation of semantic drug cue-elicited effective brain connectivity in persons with cocaine and opioid use disorders. | Ma L et al. | β | 2025 | β |
| Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo. | Spies M et al. | β | 2023 | β |
| Improved connectivity and cognition due to cognitive stimulation in Alzheimer's disease. | Behfar Q et al. | β | 2023 | β |
| A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A). | Guardiola-Ripoll M et al. | β | 2022 | β |
| Combining fMRI and DISC1 gene haplotypes to understand working memory-related brain activity in schizophrenia. | Guardiola-Ripoll M et al. | β | 2022 | β |
| G-CuP: the effect of a forced oral glucose intake on alcohol craving and mesolimbic cue reactivity in alcohol dependence-study protocol of a randomized, double-blind, placebo-controlled crossover study. | Wetzel L et al. | β | 2022 | β |
| Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients. | Wefel JS et al. | β | 2022 | β |
| Imaging Genetics in Epilepsy: Current Knowledge and New Perspectives. | Wang G et al. | β | 2022 | β |
| Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk. | Mohammadi-Nejad AR et al. | β | 2022 | β |
| New insights of the role of the KCNH2 gene in schizophrenia: An fMRI case-control study. | Guardiola-Ripoll M et al. | β | 2022 | β |
| Regional gene expression patterns are associated with task-specific brain activation during reward and emotion processing measured with functional MRI. | Komorowski A et al. | β | 2022 | β |
| Sex differences in neural substrates of risk taking: Implications for sex-specific vulnerabilities to internet gaming disorder. | Wang L et al. | β | 2022 | β |
| Brain structure and function show distinct relations with genetic predispositions to mental health and cognition | Liu S et al. | β | 2021 | β |
| Genome-wide mapping of brain phenotypes in extended pedigrees with strong genetic loading for bipolar disorder. | Fears SC et al. | β | 2021 | β |
| Neural substrates of deficient cognitive control in individuals with severe internet gaming disorder. | Wang L et al. | β | 2021 | β |
| Neuroimaging genetic associations between <i>SEMA6D</i>, brain structure, and reading skills. | Thomas T et al. | β | 2021 | β |
| Neuroprotective effect of Val variant of BDNF Val66Met polymorphism on hippocampus is modulated by the severity of menstrual pain. | Li WC et al. | β | 2021 | β |
| Ethical issues in global neuroimaging genetics collaborations. | Palk A et al. | β | 2020 | β |
| The IMAGEN study: a decade of imaging genetics in adolescents. | Mascarell MariΔiΔ L et al. | β | 2020 | β |
| The role of altered brain structural connectivity in resilience, vulnerability, and disease expression to schizophrenia. | Wei Q et al. | β | 2020 | β |
| A systematic review of factors that influence the efficacy of cognitive remediation therapy in schizophrenia. | Reser MP et al. | β | 2019 | β |
| Neural response to emotional faces in monozygotic twins: association with familial risk of affective disorders | Meluken I et al. | β | 2019 | β |
| Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia. | Lin D et al. | β | 2018 | β |
| Effects of MiR-137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls. | Cosgrove D et al. | β | 2018 | β |
| Imaging genetics of schizophrenia in the post-GWAS era. | Arslan A | β | 2018 | β |
| Mapping the Schizophrenia Genes by Neuroimaging: The Opportunities and the Challenges. | Arslan A | β | 2018 | β |
| Abnormalities of localized connectivity in schizophrenia patients and their unaffected relatives: a meta-analysis of resting-state functional magnetic resonance imaging studies. | Xiao B et al. | β | 2017 | β |
| Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity. | Klein M et al. | β | 2017 | β |
| CACNA1C polymorphisms Impact Cognitive Recovery in Patients with Bipolar Disorder in a Six-week Open-label Trial. | Lin K et al. | β | 2017 | β |
| Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working Memory. | Cosgrove D et al. | β | 2017 | β |
| FKBP5 modulates the hippocampal connectivity deficits in depression: a study in twins. | CΓ³rdova-Palomera A et al. | β | 2017 | β |
| Genetic Variants in CSMD1 Gene Are Associated with Cognitive Performance in Normal Elderly Population. | Stepanov V et al. | β | 2017 | β |
| Hippocampal-prefrontal connectivity as a translational phenotype for schizophrenia. | BΓ€hner F et al. | β | 2017 | β |
| Imaging genetics in neurodevelopmental psychopathology. | Klein M et al. | β | 2017 | β |
| Neuroimaging genomics in psychiatry-a translational approach. | Mufford MS et al. | β | 2017 | β |
| Predicting Cognitive Executive Functioning with Polygenic Risk Scores for Psychiatric Disorders. | Benca CE et al. | β | 2017 | β |
| Corticolimbic anatomical characteristics predetermine risk for chronic pain. | Vachon-Presseau E et al. | β | 2016 | β |
| Estrogen- and progesterone-mediated structural neuroplasticity in women: evidence from neuroimaging. | Catenaccio E et al. | β | 2016 | β |
| Genetic and Environmental Factors Associated with Cannabis Involvement. | Bogdan R et al. | β | 2016 | β |
| Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. | Franke B et al. | β | 2016 | β |
| Genetic Moderation of Stress Effects on Corticolimbic Circuitry. | Bogdan R et al. | β | 2016 | β |
| Offspring of Parents with Schizophrenia: A Systematic Review of Developmental Features Across Childhood. | Hameed MA et al. | β | 2016 | β |
| A genome-wide supported psychiatric risk variant in NCAN influences brain function and cognitive performance in healthy subjects. | Raum H et al. | β | 2015 | β |
| Altered amygdalar resting-state connectivity in depression is explained by both genes and environment. | CΓ³rdova-Palomera A et al. | β | 2015 | β |
| Candidate gene-environment interaction research: reflections and recommendations. | Dick DM et al. | β | 2015 | β |
| Elevated P3b latency variability in carriers of ZNF804A risk allele for psychosis. | Saville CW et al. | β | 2015 | β |
| Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. | Gupta CN et al. | β | 2015 | β |
| Genetics, sleep and memory: a recall-by-genotype study of ZNF804A variants and sleep neurophysiology. | Hellmich C et al. | β | 2015 | β |
| Neural correlates during working memory processing in major depressive disorder. | Wang XL et al. | β | 2015 | β |
| Neural Mechanism of a Sex-Specific Risk Variant for Posttraumatic Stress Disorder in the Type I Receptor of the Pituitary Adenylate Cyclase Activating Polypeptide. | Pohlack ST et al. | β | 2015 | β |
| Regulators of G-protein-signaling proteins: negative modulators of G-protein-coupled receptor signaling. | Woodard GE et al. | β | 2015 | β |
| Variation in the Williams syndrome GTF2I gene and anxiety proneness interactively affect prefrontal cortical response to aversive stimuli. | Jabbi M et al. | β | 2015 | β |
| A functional polymorphism of the MAOA gene is associated with neural responses to induced anger control. | Denson TF et al. | β | 2014 | β |
| A review of multivariate analyses in imaging genetics. | Liu J et al. | β | 2014 | β |
| CACNA1C, schizophrenia and major depressive disorder in the Han Chinese population. | He K et al. | β | 2014 | β |
| Cortical thickness as a contributor to abnormal oscillations in schizophrenia? | Edgar JC et al. | β | 2014 | β |
| Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style. | Rose EJ et al. | β | 2014 | β |
| Further evidence for the impact of a genome-wide-supported psychosis risk variant in ZNF804A on the Theory of Mind Network. | Mohnke S et al. | β | 2014 | β |
| Neural network activation during a stop-signal task discriminates cocaine-dependent from non-drug-abusing men. | Elton A et al. | β | 2014 | β |
| Prefrontal inefficiency is associated with polygenic risk for schizophrenia. | Walton E et al. | β | 2014 | β |
| The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. | Thompson PM et al. | β | 2014 | β |
| Disorders and borders: psychiatric genetics and nosology. | Smoller JW | β | 2013 | β |
| Effects of the neurogranin variant rs12807809 on thalamocortical morphology in schizophrenia. | Thong JY et al. | β | 2013 | β |
| Guided exploration of genomic risk for gray matter abnormalities in schizophrenia using parallel independent component analysis with reference. | Chen J et al. | β | 2013 | β |
| Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253. | Rose EJ et al. | β | 2013 | β |
| Neuroimaging as a potential biomarker to optimize psychiatric research and treatment. | Walton E et al. | β | 2013 | β |
| Neuroimaging schizophrenia: a picture is worth a thousand words, but is it saying anything important? | Ahmed AO et al. | β | 2013 | β |
| Potential bias in meta-analyses of effect sizes in imaging genetics. | Paulus FM et al. | β | 2013 | β |
| The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia. | Ohi K et al. | β | 2013 | β |
| CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. | Bhat S et al. | β | 2012 | β |